These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33561443)

  • 1. Quantitative assessment of glioblastoma phenotypes in vitro establishes cell migration as a robust readout of Crk and CrkL activity.
    Park T; Large N; Curran T
    J Biol Chem; 2021; 296():100390. PubMed ID: 33561443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast Growth Requires CT10 Regulator of Kinase (Crk) and Crk-like (CrkL).
    Park T; Koptyra M; Curran T
    J Biol Chem; 2016 Dec; 291(51):26273-26290. PubMed ID: 27807028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crk adaptor proteins act as key signaling integrators for breast tumorigenesis.
    Fathers KE; Bell ES; Rajadurai CV; Cory S; Zhao H; Mourskaia A; Zuo D; Madore J; Monast A; Mes-Masson AM; Grosset AA; Gaboury L; Hallet M; Siegel P; Park M
    Breast Cancer Res; 2012 May; 14(3):R74. PubMed ID: 22569336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crk and CrkL as Therapeutic Targets for Cancer Treatment.
    Park T
    Cells; 2021 Mar; 10(4):. PubMed ID: 33801580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential roles of Crk and CrkL in fibroblast structure and motility.
    Park TJ; Curran T
    Oncogene; 2014 Oct; 33(43):5121-32. PubMed ID: 24166500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CrkL efficiently mediates cell proliferation, migration, and invasion induced by TGF-β pathway in glioblastoma.
    Lv S; Qin J; Yi R; Coreman M; Shi R; Kang H; Yao C
    J Mol Neurosci; 2013 Nov; 51(3):1046-51. PubMed ID: 23959425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crk and CrkL present with different expression and significance in epithelial ovarian carcinoma.
    Wang J; Che YL; Li G; Liu B; Shen TM; Wang H; Linghu H
    Mol Carcinog; 2011 Jul; 50(7):506-15. PubMed ID: 21319228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRKL regulates alternative splicing of cancer-related genes in cervical cancer samples and HeLa cell.
    Song Q; Yi F; Zhang Y; Jun Li DK; Wei Y; Yu H; Zhang Y
    BMC Cancer; 2019 May; 19(1):499. PubMed ID: 31133010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DOCK5 and DOCK1 regulate Caco-2 intestinal epithelial cell spreading and migration on collagen IV.
    Sanders MA; Ampasala D; Basson MD
    J Biol Chem; 2009 Jan; 284(1):27-35. PubMed ID: 19004829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reciprocal regulation of Abl kinase by Crk Y251 and Abi1 controls invasive phenotypes in glioblastoma.
    Kumar S; Lu B; Dixit U; Hossain S; Liu Y; Li J; Hornbeck P; Zheng W; Sowalsky AG; Kotula L; Birge RB
    Oncotarget; 2015 Nov; 6(35):37792-807. PubMed ID: 26473374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct roles for Crk adaptor isoforms in actin reorganization induced by extracellular signals.
    Antoku S; Mayer BJ
    J Cell Sci; 2009 Nov; 122(Pt 22):4228-38. PubMed ID: 19861495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CrkI adapter protein modulates cell migration and invasion in glioblastoma.
    Takino T; Nakada M; Miyamori H; Yamashita J; Yamada KM; Sato H
    Cancer Res; 2003 May; 63(9):2335-7. PubMed ID: 12727859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-7-induced phosphorylation of the adaptor Crk-like and other targets.
    Aiello FB; Guszczynski T; Li W; Hixon JA; Jiang Q; Hodge DL; Massignan T; Di Lisio C; Merchant A; Procopio AD; Bonetto V; Durum SK
    Cell Signal; 2018 Jul; 47():131-141. PubMed ID: 29581031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement for Crk and CrkL during postnatal lens development.
    Park T; Curran T
    Biochem Biophys Res Commun; 2020 Aug; 529(3):603-607. PubMed ID: 32736680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential role of the
    Imamoto A; Ki S; Li L; Iwamoto K; Maruthamuthu V; Devany J; Lu O; Kanazawa T; Zhang S; Yamada T; Hirayama A; Fukuda S; Suzuki Y; Okada M
    Life Sci Alliance; 2020 Feb; 3(2):. PubMed ID: 32041892
    [No Abstract]   [Full Text] [Related]  

  • 16. Knockdown of CkrL by shRNA deteriorates hypoxia/reoxygenation-induced H9C2 cardiomyocyte apoptosis and survival inhibition Via Bax and downregulation of P-Erk1/2.
    Zhang ZS; Yang DY; Fu YB; Zhang L; Zhao QP; Li G
    Cell Biochem Funct; 2015 Mar; 33(2):80-8. PubMed ID: 25703803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crk and CrkL are required for cell transformation by v-fos and v-ras.
    Koptyra M; Park TJ; Curran T
    Mol Carcinog; 2016 Jan; 55(1):97-104. PubMed ID: 25557916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of phosphotyrosine-containing peptides to target SH2 domains: Antagonist peptides of the Crk/CrkL-p130Cas axis.
    Douglas JT; Johnson DK; Roy A; Park T
    Methods Enzymol; 2024; 698():301-342. PubMed ID: 38886037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling adaptor protein Crk is indispensable for malignant feature of glioblastoma cell line KMG4.
    Wang L; Tabu K; Kimura T; Tsuda M; Linghu H; Tanino M; Kaneko S; Nishihara H; Tanaka S
    Biochem Biophys Res Commun; 2007 Nov; 362(4):976-81. PubMed ID: 17825249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRKL but not CRKII contributes to hemin-induced erythroid differentiation of CML.
    Guo C; Lv X; Zhang Q; Yi L; Ren Y; Li Z; Yan J; Zheng S; Sun MZ; Liu S
    J Cell Mol Med; 2024 May; 28(9):e18308. PubMed ID: 38683131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.